Camels' biological fluids contained nanobodies: promising avenue in cancer therapy

Nouf S Al-Numair1,2, Abdulrahman Theyab3,4, Faisal Alzahrani5,6

  • 1Center of Genomic Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.

Cancer Cell International
|September 7, 2022
PubMed

Insights

Camel-derived nanobodies offer a novel nanotechnology approach for cancer therapy. These small, stable biologics show potential for deep tissue penetration, aiding in cancer diagnosis and treatment.

Area of Science:

  • Oncology
  • Nanotechnology
  • Biotechnology

Background:

  • Cancer remains a leading global cause of mortality, necessitating innovative diagnostic and therapeutic strategies.
  • Camel-derived nanobodies are emerging as promising tools in oncology due to their unique properties.

Purpose of the Study:

  • To review the potential of camel-derived nanobodies in nanotechnology-based cancer therapy.
  • To explore the role of nanoproteomics in developing novel cancer therapeutic agents.

Main Methods:

  • Review of current literature on camel-derived nanobodies and their applications in cancer.
  • Discussion of nanobody characteristics, including size, tissue penetration, and stability.
  • Exploration of nanoproteomics for therapeutic agent discovery.

Main Results:

  • Nanobodies are small, stable biologics facilitating deep tissue penetration.
  • Camel milk and urine are sources of nanobodies with therapeutic potential.
  • Nanoproteomics can aid in identifying novel cancer intervention agents.

Conclusions:

  • Camel-derived nanobodies represent a viable nanotechnology for developing novel cancer treatments.
  • Further research into nanobody applications and nanoproteomics can advance cancer therapy.